PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-mouse CD107a (LAMP-1), 25 μg
PE/Dazzle™ 594 anti-mouse CD115 (CSF-1R), 100 μg
PE/Dazzle™ 594 anti-mouse CD115 (CSF-1R), 25 μg
PE/Dazzle™ 594 anti-mouse CD117 (c-kit), 100 μg
PE/Dazzle™ 594 anti-mouse CD117 (c-Kit), 100 μg
PE/Dazzle™ 594 anti-mouse CD117 (c-kit), 25 μg
PE/Dazzle™ 594 anti-mouse CD117 (c-Kit), 25 μg
PE/Dazzle™ 594 anti-mouse CD11c, 100 μg
PE/Dazzle™ 594 anti-mouse CD11c, 25 μg
PE/Dazzle™ 594 anti-mouse CD122 (IL-2Rβ), 100 μg
PE/Dazzle™ 594 anti-mouse CD122 (IL-2Rβ), 25 μg
PE/Dazzle™ 594 anti-mouse CD127 (IL-7Rα), 100 μg
PE/Dazzle™ 594 anti-mouse CD127 (IL-7Rα), 25 μg
PE/Dazzle™ 594 anti-mouse CD133, 100 μg
PE/Dazzle™ 594 anti-mouse CD133, 25 μg
PE/Dazzle™ 594 anti-mouse CD134 (OX-40), 100 μg